Reuters logo
10 months ago
BRIEF-Medicinova says FDA granted orphan drug designation to MN-166 for ALS
October 11, 2016 / 11:11 PM / 10 months ago

BRIEF-Medicinova says FDA granted orphan drug designation to MN-166 for ALS

Oct 11 (Reuters) - Medicinova Inc :

* Medicinova announces FDA granted orphan drug designation to MN-166 (ibudilast) for amyotrophic lateral sclerosis

* Medicinova INC -MN-166 demonstrated positive trends in interim efficacy data from mid-study analysis of CHS Neuromuscular/ALS-MDA center study Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below